Drug Approval | April 21, 2022
Dr. Reddy's launch Posaconazole delayed-release tablets in the US
The tablets are available in 100 mg strength in bottle count sizes of 60
The tablets are available in 100 mg strength in bottle count sizes of 60
Strive to empower public health with disinfection robotics solutions in post-pandemic era
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
Subscribe To Our Newsletter & Stay Updated
